China Resources Pharmaceutical Group (03320.HK): Kunyu Group's net profit attributable to shareholders in the first half of the year was approximately 1.98 billion yuan, a decrease of 26.88% year-on-year.

Chinastocks APP News, CR Pharma (03320.HK) announced Kunxin Group's performance in the first half of 2025, with total operating income of approximately 3.351 billion yuan, a year-on-year decrease of 11.68%; the company's shareholders' net profit attributable to listed companies is approximately 198 million yuan, a year-on-year decrease of 26.88%; basic earnings per share is 0.26 yuan.